Benjamin Bauer
Foot & Ankle Surgery · Las Vegas, NVNPI 1417392481
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (50.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Goode Surgical Inc accounts for 70.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2020 at $3,488 and has fallen 95.7% since, to $150 in 2025.
Across 85 payments — averaging $81.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Goode Surgical Inc$5K
- Arthrex$567
- Smith+Nephew$212
- Zimmer Biomet$183
- Trimed, Inc.$148
- Stryker$145
- plus $834 from 18 others
What the payments were for
- Travel & lodging$1,80126%
- Food & beverage$1,62823%
- Education$3,54151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Goode Surgical Inc | 8 | $4,880 |
| Arthrex | 8 | $567 |
| Smith+Nephew | 17 | $212 |
| Zimmer Biomet | 3 | $183 |
| Trimed, Inc. | 1 | $148 |
| Stryker(2 entities) | 6 | $145 |
| Treace Medical Concepts, Inc. | 5 | $125 |
| Organogenesis Inc. | 4 | $123 |
| Amgen(2 entities) | 4 | $86 |
| AbbVie | 4 | $77 |
| Abbott | 4 | $65 |
| Bioventus LLC | 3 | $63 |
| Orthofix Medical, Inc. | 4 | $52 |
| Kowa Pharmaceuticals America, Inc. | 3 | $44 |
| Merck | 2 | $33 |
| Nevro Corp. | 1 | $31 |
| Integra Lifesciences Corporation | 1 | $24 |
| Cardiovascular Systems Inc. | 1 | $21 |
| Solventum Corporation | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $19 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Medtronic | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nextremity InCore$137
- Foot&Ankle-Subchondroplasty$137
- Stratum Foot Plating System$137
How this compares
$6,970 in reported general payments places this provider in the 70th percentile of 84 foot & ankle surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 93 | $2,514 |
| Gabapentin | 23 | $498 |
| Ammonium Lactate | 14 | $309 |
| Ketoconazole | 11 | $207 |
| Doxycycline Hyclate | 16 | $163 |
| Methylprednisolone | 17 | $126 |
| Meloxicam | 26 | $59 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Las Vegas
- Troy WatsonLas Vegas$1.2M
- Ira WeinerLas Vegas$135K
- Abdolreza RaissiLas Vegas$110K
- Anthony BorgiaLas Vegas$47K
- Nahad WasselLas Vegas$24K
- Casey BurchillLas Vegas$20K
- Timothy BrookesLas Vegas$14K
- Daniel HallmanLas Vegas$12K
- Grant BeckLas Vegas$10K
- Thomman KuruvillaLas Vegas$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.